A Study to Evaluate the Effect of LY2189265 on Gastric Emptying Using Scintigraphy in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase I
Latest Information Update: 12 Nov 2014
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Eli Lilly
- 04 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Dec 2010 Planned End Date changed from 1 Apr 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 12 Oct 2010 New trial record